CXCR4 antagonist 3
CXCR4 antagonist 3 (compound 12a) is a potent antagonist of CXCR4 with an IC50 of 11 nM. CXCR4 antagonist 3 is a congener of TIQ15. CXCR4 antagonist 3 demonstrates the best overall properties including CXCR4 antagonism, CYP 2D6 inhibition, metabolic stability, and permeability. CXCR4 antagonist 3 has the potential for the research of human immunodeficiency virus[1].
Product Specifications
CAS Number
2761009-43-0
UNSPSC
12352005
Target
CXCR
Type
Reference compound
Related Pathways
GPCR/G Protein; Immunology/Inflammation
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/cxcr4-antagonist-3.html
Solubility
10 mM in DMSO
Smiles
NCCCCN([C@@H]1C2=NC=CC=C2CCC1)C[C@@H]3NCC4=C(C3)N=CC=C4
Molecular Formula
C22H31N5
Molecular Weight
365.52
References & Citations
[1]Jecs E, et al. Synthesis and Evaluation of Novel Tetrahydronaphthyridine CXCR4 Antagonists with Improved Drug-like Profiles. J Med Chem. 2022;65 (5) :4058-4084.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CXCR4
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
AZA4IGC8-Biotin 100 µg/Vial
Anti-Zebrafish P5CS/ALDH18A1 Antibody Biotin Conjugated
Sign In for Pricing
View Details 
124218-PE 100 µL
CACNG1 (Voltage-dependent Calcium Channel gamma-1 Subunit, Dihydropyridine-sensitive L-type, Skeletal Muscle Calcium Channel Subunit gamma, CACNLG) (PE)
Sign In for Pricing
View Details